Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

nice_new_london_office_internal_3_web

NICE approves Sanofi’s Sarclisa combo for relapsed/refractory multiple myeloma

October 16, 2020 Medical Communications, Sales and Marketing NICE, Sanofi, Sarclisa, multiple myeloma

Sanofi’s Sarclisa (isatuximab) has secured a recommendation from NICE for routine use on the NHS in England and Wales as …
News
piccadilly_circus_station_during_london_covid-19_lockdown

80 researchers argue COVID-19 herd immunity strategy is a “dangerous fallacy” in open letter

October 15, 2020 Medical Communications, Research and Development, Sales and Marketing COVID-19

A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the …
News

Scottish Medicines Consortium gives go-ahead for Novartis’ Mayzent in secondary progressive multiple sclerosis

October 15, 2020 Sales and Marketing Mayzent, Novartis, Scotland

Novartis’ Mayzent (siponimod) has been approved by the Scottish Medicines Consortium in the treatment of secondary progressive multiple sclerosis (SPMS) …
News
shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

October 14, 2020 Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
News
bavencio

Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020 Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …
News
shutterstock_3

University of Glasgow research details promising precision medicine approach in pancreatic cancer

October 12, 2020 Research and Development, Sales and Marketing Cancer, Precision Medicine

Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …
News
citizens_of_wuhan_lining_up_outside_of_a_drug_store_to_buy_masks_during_the_wuhan_coronavirus_outbreak

China to test entire population of Qingdao over nine days

October 12, 2020 Sales and Marketing coivd-19, coronavirus, pandemic, virus

China plans to test the entire city of Qingdao, containing nine million people, for coronavirus over a period of five …
News
800px-joe_biden_48554137807

Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election

October 12, 2020 Sales and Marketing

The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead …
News
800px-new_zealand_parliament_house_in_2016

New Zealand Government signs deal with Pfizer and BioNTech for 1.5 million COVID-19 vaccines

October 12, 2020 Sales and Marketing

The New Zealand Government has signed a deal with Pfizer and BioNTech for one of their promising COVID-19 vaccine candidates.  …
News
download_3

Sun Pharma issues recall of its generic diabetes drug in US market

October 12, 2020 Sales and Marketing FDA, diabetes, recall

Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.This is due to an …
News

Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

October 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Eggan, appointments

BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He …
Appointment
david_nicholson

Allergan R&D Chief named as Chairman of Exscientia’s Board of Directors

October 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Exscientia, appointment

Artificial intelligence-driven drug discovery firm Exscientia has named industry veteran Dr David Nicholson, current Executive Vice President and Chief R&D …
Appointment
glenmark

FDA greenlights Glenmark’s generic version of Biogen’s Tecfidera in relapsing multiple sclerosis

October 7, 2020 Research and Development, Sales and Marketing Biogen, Glenmark, generic, multiple sclerosis

Glenmark Pharma will be celebrating after it secured FDA approval in the US to market dimethyl fumarate, a generic version …
News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020 Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
News
bel-n-garijo-large

Company veteran Belén Garijo named as Merck KGaA’s first-ever female CEO

October 6, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

German pharma firm Merck KGaA has taken the decision to appoint its first female Chief Executive Officer in its 352-year …
Appointment
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026